MacroGenics
MGNX
#9452
Rank
โ‚ฌ0.11 B
Marketcap
1,79ย โ‚ฌ
Share price
-1.01%
Change (1 day)
45.14%
Change (1 year)

Earnings for MacroGenics (MGNX)

Earnings in 2026 (TTM): -โ‚ฌ91.17 Million

According to MacroGenics's latest financial reports the company's current earnings are โ‚ฌ0.16 Billion. In 2025 the company made an earning of -โ‚ฌ74.54 Million a decrease over its 2024 earnings that were of -โ‚ฌ60.19 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for MacroGenics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ91.17 Million22.32%
2025 -โ‚ฌ74.54 Million23.83%
2024 -โ‚ฌ60.19 Million628.88%
2023 -โ‚ฌ8.26 Million-92.44%
2022 -โ‚ฌ0.11 Billion-40.75%
2021 -โ‚ฌ0.19 Billion55.79%
2020 -โ‚ฌ0.12 Billion-14.54%
2019 -โ‚ฌ0.14 Billion-11.46%
2018 -โ‚ฌ0.16 Billion773.65%
2017 -โ‚ฌ17.9 Million-66.47%
2016 -โ‚ฌ53.36 Million190.61%
2015 -โ‚ฌ18.36 Million-47.43%
2014 -โ‚ฌ34.93 Million14585.78%
2013 -โ‚ฌ0.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ6.35 B-6,766.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ31.69 B-33,363.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ10.07 B-10,673.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚ฌ2.31 Billion 2,323.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.12 B-6,531.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.33 B-10,941.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚ฌ0.11 Billion 10.56%๐Ÿ‡บ๐Ÿ‡ธ USA